| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.39▲ | 2.39▲ | 2.39▲ | 2.44▲ | 2.39▲ |
| MA10 | 2.36▲ | 2.36▲ | 2.36▲ | 2.38▲ | 3.45▼ |
| MA20 | 2.31▲ | 2.29▲ | 2.29▲ | 2.41▲ | 4.14▼ |
| MA50 | 2.32▲ | 2.36▲ | 2.60▲ | 3.66▼ | 5.69▼ |
| MA100 | 2.96▼ | 3.31▼ | 3.56▼ | 4.25▼ | 4.38▼ |
| MA200 | 3.76▼ | 4.09▼ | 4.23▼ | 5.32▼ | 3.88▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.032▲ | 0.050▲ | 0.062▲ | 0.103▲ | -0.193▼ |
| RSI | 70.759▲ | 65.983▲ | 63.514▲ | 42.185▼ | 31.558▼ |
| STOCH | 56.250 | 64.583 | 64.583 | 60.119 | 14.298▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -13.538▲ | -84.493▼ |
| CCI | 382.155▲ | 370.240▲ | 370.240▲ | 209.362▲ | -95.474 |
| ▲ PSAR&MOM | $PULM PSAR Switch Up + Momentum | Set Alert |
|
Wednesday, December 17, 2025 09:05 PM
FRAMINGHAM, Mass., Dec. 18, 2025 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/01/26 | 2.53 | 2.69 | 2.46 | 2.625 | 16,977 |
| 15/01/26 | 2.35 | 2.70 | 2.35 | 2.53 | 32,064 |
| 14/01/26 | 2.32 | 2.4988 | 2.30 | 2.37 | 19,549 |
| 13/01/26 | 2.35 | 2.38 | 2.29 | 2.33 | 7,538 |
| 12/01/26 | 2.38 | 2.5775 | 2.23 | 2.35 | 19,800 |
| 09/01/26 | 2.36 | 2.40 | 2.36 | 2.36 | 12,637 |
| 08/01/26 | 2.28 | 2.39 | 2.27 | 2.35 | 24,653 |
| 07/01/26 | 2.29 | 2.35 | 2.275 | 2.30 | 9,891 |
| 06/01/26 | 2.29 | 2.35 | 2.25 | 2.30 | 22,508 |
| 05/01/26 | 2.27 | 2.3599 | 2.25 | 2.27 | 14,559 |
|
|
||||
|
|
||||
|
|